PubMed

Opportunities and Challenges in Precision Neurotherapeutics.

PMID: 41543941 · 2026-01-16

L, i, l, i, a, n, n, e, , R, , M, u, j, i, c, a, -, P, a, r, o, d, i, ;, , D, o, s, t, , Ö, n, g, ü, r, ;, , R, , M, a, r, k, , R, i, c, h, a, r, d, s, o, n

ЖурналAnnual review of biomedical engineering

Год2026-01-16

PMID41543941

Аннотация

Precision neurotherapeutics represents a transformative paradigm shift from standardized "one-size-fits-all" treatments of neurological, neurodegenerative, and/or psychiatric disorders toward individualized interventions that leverage patient-specific biological, behavioral, and physiological characteristics. Traditional neurotherapeutic approaches achieve modest response rates of 30-60% for first-line treatments, necessitating personalized strategies that account for individual differences in g

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.